Radiopharmaceuticals companies

  • Report ID: 6519
  • Published Date: Aug 14, 2025
  • Report Format: PDF, PPT

Key Radiopharmaceuticals Market Players:

    There are both large pharmaceutical enterprises and specialized businesses in this competitive sector. Leading companies set themselves apart via technological innovations, intensive research and development, and calculated alliances. While rising players concentrate on specialty technologies and novel medicines, established companies make use of their resources and worldwide reach. Quality and regulatory compliance are vital, and businesses must adhere to strict requirements. Pricing and customer service tactics can have an impact on competition since businesses want to provide value and top-notch assistance. All things considered, the radiopharmaceuticals market is dynamic, propelled by ongoing innovation and a concentration on upholding strict standards for both product development and customer service.

    Here are some leading players in the radiopharmaceuticals market:

    • PharmaLogic Holdings Corp.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • Bayer AG
    • Bracco
    • Cardinal Health Inc.
    • Coquí Radiopharmaceuticals Corp
    • Curium Pharma
    • Eli Lilly and Company
    • General Electric Company
    • IRE EliT
    • Bristol Myers Squibb

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of radiopharmaceuticals is estimated at USD 7.49 billion.

Radiopharmaceuticals Market size was over USD 6.92 billion in 2025 and is poised to exceed USD 16.69 billion by 2035, growing at over 9.2% CAGR during the forecast period i.e., between 2026-2035.

North America leads the Radiopharmaceuticals Market with a 49.2% share, propelled by a strong healthcare ecosystem, R&D investments, and high prevalence of chronic illnesses, ensuring strong growth through 2035.

Key players in the market include Bayer AG, Bracco, Cardinal Health Inc., Coquí Radiopharmaceuticals Corp, Curium Pharma, Eli Lilly and Company, General Electric Company, IRE EliT, and Bristol Myers Squibb.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos